In a ruling handed down on October 18, 2025, the CJEU ruled in Case C-2/24 P, Teva v. Cephalon v. European Commission, clarifying the conditions under which an amicable settlement agreement between patent holders and generic manufacturers can be classified as an anti-competitive agreement. In this article, Renaud Christol and Paul Vialard review the implications […]
| COMPETITION AND ECONOMIC LAW